Clinical breakthroughs in immunotherapy from SITC 2022
VJOncology are excited to highlight the latest in immuno-oncology from the 37th Annual Meeting of the Society for Immunotherapy in…
MOUNTAINEER: Tucatinib plus trastuzumab demonstrates good efficacy for the treatment of HER2-positive metastatic colorectal cancer
In the U.S., colorectal cancer (CRC) is the third leading cause of cancer-related deaths and is expected to lead to…
Highlights from ASCO 2022
VJOncology are excited to present our top picks from the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting!
Highlights from ASCO GI 2022
VJOncology brings you highlights in GI cancer from this year’s virtual American Society of Clinical Oncology (ASCO) Gastrointestinal Cancer Symposium!
Top 5 in GI from ASCO 2021
VJOncology brings you highlights in GI cancer from this year’s virtual American Society of Clinical Oncology (ASCO) annual meeting!
ASCO GI 2021 Highlights
VJOncology are excited to present some key abstracts and trial updates announced at this year’s virtual ASCO GI meeting!
TP53 mutations predict sensitivity to adjuvant chemotherapy in pancreatic cancers
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive gastrointestinal malignancy and is often associated with a poor prognosis. Surgery remains…